Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/22/16 → 05/21/18 |
Funding
- PTC Therapeutics Inc: $26,192.50
A Phase 3 Extension Study of Ataluren (PTC124) in Patients with Nonsense Mutation Cystic Fibrosis
- Fortner, Christopher (PI)
- Sexton, James (CoI)
Project: Research